Monthly Archives: August 2011

Walter Reed Program delivers on science and care in Kericho, Kenya

By on .

The following is a post from Center for Global Health Policy Director Christine Lubinski, who recently traveled to Kenya with a group of Capitol Hill staff from key Congressional offices with jurisdiction over global health funding or programs.

Amidst the beautiful tea plantations of Kericho, the Kenya Medical Research Institute (KEMRI)/Walter Reed Program supports research and clinical excellence. This effective Kenyan/U.S. government partnership has brought research training and good jobs for Kenyans and lifesaving clinical care to many…

Activists warn trade agreements could impact access to affordable medicines in poor countries

By on .

On September 10, the 8th round of negotiations for the Trans-Pacific Partnership Trade Agreement (TPPA) – a controversial pact between the U.S. and eight countries in the Asia-Pacific region – will be taking place in Chicago. The meeting will include trade representatives from the U.S., Australia, Brunei, Chile, Malaysia, New Zealand, Peru, Singapore and Vietnam – and other stakeholders such as corporations with global interests.

The negotiations will consider inclusion of pre-grant opposition procedures, a process which allows interested parties to submit information to the patent examiner before deciding whether or not to approve a drug firm’s application for a patent. Global health advocates argue that the process facilitates increased access to affordable medicines…

AMPATH builds comprehensive health care services for Kenyans on PEPFAR platform

By on .

During a recent visit to Kenya with a group of Capitol Hill staff from key Congressional offices, Center for Global Health Policy Director Christine Lubinski toured AMPATH – a consortium that has created a broad range of health care services and programs with strong community engagement in Western Kenya. This post describes their extensive services…

PEPFAR 2012 Country Operational Guidance includes special section on HIV/TB

By on .

Part of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program’s recently released 2012 Country Operational Plan Guidance, the TB/HIV Technical Considerations highlight the important role of tuberculosis prevention and treatment in successfully combating the HIV pandemic. The updated “considerations” take into account the 2011 World Health Organization (WHO) “Guidelines for intensified tuberculosis case-finding […]

Gates Foundation seeks Grand Challenges grant applicants

By on .

The 8th round of the Grand Challenges Explorations, an initiative of The Bill & Melinda Gates Foundation, is accepting grant proposals for innovative and unconventional global health and development solutions. The online applications will be accepted until Nov. 17, 2011. Specific to global health, the Foundation is seeking proposals that focus on: designing new approaches […]

PEPFAR releases 2012 Country Operational Plan Guidance

By on .

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program released the 2012 Country Operational Plan Guidance recently, which highlights seven program priorities: increasing prevention of mother–to-child transmission (PMTCT) coverage and effectiveness; improving and refining the country’s approach to treatment; programming for prevention impact; TB/HIV integration; testing and counseling; training new healthcare providers; and capacity […]

Measles outbreak compounds famine relief efforts in horn of Africa

By on .

The White House convened a call with faith-based organizations Wednesday afternoon to discuss efforts in the horn of Africa to combat the extensive famine brought on by a severe drought in the region, the worst seen in decades. The famine has already claimed the lives of approximately 29,000 children. The call included U.S. envoy participants […]

Scientists find new antibodies to help in HIV vaccine quest

By on .

In a new article published today in the journal Nature, a team of researchers reported the isolation of 17 novel antibodies capable of deactivating a broad spectrum of HIV variants – which could be huge in the development of an HIV vaccine.

The team of researchers hailed from the International AIDS Vaccine Initiative (IAVI), the Scripps Research Institute, Theraclone Sciences and Monogram Biosciences Inc.

Science Speaks interviewed one of the paper’s co-authors, Wayne C. Koff, PhD, on this exciting new science to get a better grasp on the thinking behind broadly neutralizing antibodies (bNAbs) and the AIDS vaccine development process.

Center tours Mbagathi District Hospital in Nairobi, Kenya with Congressional staff

By on .

The following is a blog post by Center for Global Health Policy Director Christine Lubinski, who is travelling in Kenya this week with a group of staffers from key U.S. Congressional offices. On day one of a week long visit to HIV and TB programs in Kenya, we visited the Mbagathi District Hospital hosted by […]

“The Gang of 12” and the future of global health funding

By on .

The heads of each party in the two chambers of Congress announced their picks this week to staff the Joint Select Committee on Deficit Reduction, which some are now calling the “Gang of 12.” The debt deal struck last week automatically implements nearly $1 trillion in cuts to be implemented over the next nine years […]